Acetylsalicylic acid 100 mg and 1000 mg daily in acute myocardial infarction suspects: a placebo‐controlled trial

Abstract Husted SE, Kraemmer Nielsen H, Krusell LR, Faergeman O (Department of Internal Medicine and Cardiology, Åarhus Amtssygehus, University Hospital, Åarhus, Denmark). Acetylsalicylic acid 100 mg and 1000 mg daily in acute myocardial infarction suspects: a placebo‐controlled trial.

[1]  B. Rabinowitz,et al.  [Aspirin in coronary heart disease]. , 1989, Harefuah.

[2]  T. Galema,et al.  Low dose aspirin after early thrombolysis in anterior wall acute myocardial infarction. , 1988, The American journal of cardiology.

[3]  R. Doll,et al.  Randomised trial of prophylactic daily aspirin in British male doctors , 1988, British medical journal.

[4]  K. McPherson,et al.  Secondary prevention of vascular disease by prolonged antiplatelet treatment , 1988, British medical journal.

[5]  Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study. , 1988, The New England journal of medicine.

[6]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico..  LONG-TERM EFFECTS OF INTRAVENOUS THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION: FINAL REPORT OF THE GISSI STUDY , 1987, The Lancet.

[7]  K. Wegscheider,et al.  Risk of death from recurrent ischemic events after intravenous streptokinase in acute myocardial infarction: results from the Intravenous Streptokinase in Myocardial Infarction (ISAM) Study. , 1987, Circulation.

[8]  R M Whitlock,et al.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.

[9]  S. Sherry.  Recombinant tissue plasminogen activator (rt-PA): is it the thrombolytic agent of choice for an evolving acute myocardial infarction? , 1987, The American journal of cardiology.

[10]  R. Kloner,et al.  Analysis of reported randomized trials of streptokinase therapy for acute myocardial infarction in the 1980s. , 1987, The American journal of cardiology.

[11]  J. Haft,et al.  Is coronary arterial spasm part of the aspirin-induced asthma syndrome? , 1986, Chest.

[12]  J. Stamler,et al.  Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin. , 1986, Journal of the American College of Cardiology.

[13]  D. Sackett,et al.  Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. , 1985, The New England journal of medicine.

[14]  M. Stampfer,et al.  Cumulative antiplatelet effect of low‐dose enteric coated aspirin , 1985, British journal of haematology.

[15]  E. Falk.  Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. , 1985, Circulation.

[16]  D. Rifkin,et al.  Aspirin inhibits vascular plasminogen activator activity in vivo. Studies utilizing a new assay to quantify plasminogen activator activity. , 1984, The Journal of clinical investigation.

[17]  P. Weber,et al.  IMPROVED AORTOCORONARY BYPASS PATENCY BY LOW-DOSE ASPIRIN (100 mg DAILY) Effects on Platelet Aggregation and Thromboxane Formation , 1984, The Lancet.

[18]  Niels Jørgen Christensen,et al.  A new automated technique for platelet aggregation measurement. , 1984, Scandinavian Journal of Clinical and Laboratory Investigation.

[19]  R M Centor,et al.  Inability to predict relapse in acute asthma. , 1984, The New England journal of medicine.

[20]  M. LeWinter,et al.  Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. , 1983, The New England journal of medicine.

[21]  G. FitzGerald,et al.  Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. , 1983, The Journal of clinical investigation.

[22]  C. Patrono,et al.  Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. , 1982, The Journal of clinical investigation.

[23]  P. Elwood.  Trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction. , 1981, British medical journal.

[24]  Lippincott Williams Wilkins,et al.  Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group. , 1980, Circulation.

[25]  J. Knudsen,et al.  Changes in Platelet Functions, Coagulation and Fibrinolysis in Uncomplicated Cases of Acute Myocardial Infarction , 1979, Thrombosis and Haemostasis.

[26]  A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. , 1980, JAMA.

[27]  P. Elwood,et al.  ASPIRIN AND SECONDARY MORTALITY AFTER MYOCARDIAL INFARCTION , 1979, The Lancet.

[28]  P. Majerus,et al.  Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. , 1979, The New England journal of medicine.

[29]  K Uberla,et al.  Secondary Prevention of Myocardial Infarction Comparison of Acetylsalicylic Acid, Phenprocoumon and Placebo , 1979, Thrombosis and Haemostasis.

[30]  P C Elwood,et al.  A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction , 1974, British medical journal.